Caberdost Tablets

Caberdost Tablets (Cabergoline 0.25 mg and 0.5 mg) - Product Information

Cabergoline (Caberdost tablets) is used to treat different types of medical conditions that occur when too much of the hormone prolactin is produced. It can be used to treat certain menstrual problems, fertility problems in men and women, and pituitary prolactinomas (tumors of the pituitary gland). Cabergoline can also be useful in the treatment of sleep disturbances associated with advanced Parkinson's disease such as nocturnal akinesia and dystonia.
Caberdost tablets which contain Cabergoline as the active ingredient, belongs to a class of medications known as dopaminergic drugs. Cabergoline enhances the amount of dopamine neurotransmitter in the brain. Caberdost tablets interacts with the dopamine receptors present on the cells to lessen the blood levels of the female hormone called prolactin, which is secreted by the pituitary gland.
Caberdost tablets are also prescribed for the effective treatment of patients suffering from Parkinson’s disease. Many body-builders and weight-training athletes take Generic Cabergoline tablets throughout the anabolic steroid cycles to enhance muscle mass. Bodybuilders also use Caberdost tablets to reduce the risk of certain undesirable side effects such as gynecomastia that occur due to the use of anabolic steroids.
Caberdost tablets are manufactured by HAB Pharmaceuticals & Research Limited, India (Signature) in the strength of 0.5 mg of Cabergoline.
We also have in stock Fertomid Tablets (Generic Clomiphene Citrate) which are useful for the stimulation of ovulation in women who are diagnosed with polycystic ovary syndrome (PCOS).

Drug Name

Caberdost tablets. Other brand names for Cabergoline tablets include Cabgolin, Actualene, Agalates, Cabaser, Cabaseril, Cabergolek, Cabergolina, Cabergolinum, Caberpar, Cabeser, Cabest, Cieldom, Galastop, Kabergolin, Lac stop, Lactamax, Lactovet, Prolastat, Sogilen, Sostilar, Triaspar.

Manufacturer of Caberdost Tablets

Caberdost tablets, available in our online pharmacy are manufactured by HAB Pharmaceuticals & Research Limited, India (Signature)  
Website: habpharma.com

Active Pharmaceutical Ingredient

The active pharmaceutical ingredient in Caberdost tablets is Cabergoline. Each Caberdost tablet contains 0.5 mg of Cabergoline.
The inactive ingredients present in Caberdost pills are leucine, USP, and lactose, NF.

What are Caberdost Tablets Used For?

Caberdost tablets, manufactured by HAB Pharmaceuticals & Research Limited, India (Signature) in strengths of 0.5 mg of Cabergoline, increases the level of dopamine neurotransmitter activity in the brain by working as a dopamine receptor agonist. Caberdost tablets are generally prescribed as oral therapy to lower the blood level of prolactin hormone in patients detected with hyperprolactinemia. Hyperprolactinemia is medical condition which is characterized by aberrantly higher blood levels of prolactin hormone due to the growth of a non-cancerous enlargement (tumor) in the pituitary gland.
Caberdost tablets(Cabergoline) are indicated for:
Treatment of hyperprolactinemic disorders:
Caberdost is indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
Inhibition of physiological lactation:
Caberdost is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons.These medical reasons may include birth of a still born baby, neonatal death, conditions interfering with suckling (cleft lip or palate of the baby), severe acute or chronic mental illness or medical conditions, maternal disease which may be transmitted to the baby that require medications which are excreted in the milk.
Patients diagnosed with the mental disorder called Parkinson’s disease are also recommended treatment with Caberdost tablets. Parkinson’s patients are found to have a reduced level of dopamine transmission in the brain. The typical symptoms of Parkinson’s disease are rigidity of the body, shaking (tremor), loss of muscle coordination, imbalance, and slow body movement. Generic Cabergoline tablets reduces the symptoms of Parkinson’s disease by intensifying the level of dopamine transmission in the brain and increasing the communication between brain cells. 
Bodybuilders participating in professional bodybuilding contests are administered Caberdost tablets (Cabergoline tablets) along with other dietary supplements during the steroid cycle to attain enlarged muscle mass and effective weight loss by losing excessive body fat.
Numerous weight training professionals and bodybuilders have used Caberdost tablets to decrease the occurrence of undesirable side effects of anabolic steroid cycle such as gynecomastia (breast enlargement).

Caberdost Dosage - How to Take Cabergoline Tablets?

You should take Caberdost tablets (Cabergoline) exactly as prescribed by your doctor. Your doctor may recommend an optimum dosage of Caberdost tablets depending on your medical condition, body weight, other medical conditions, and current medications. Cabergoline can be administered once or twice a day along with a glass of water, after a meal to avoid gastrointestinal problems. Try to keep a consistent schedule for the medicine such that you take Generic Cabergoline tablets at the same time daily, to acquire the maximum advantage of the medication.
Doctors usually prescribe a dosage of 0.25 mg Caberdost tablet (Cabergoline), administered twice a week. Your doctor will steadily increase the dosage of Caberdost tablets through the next few weeks depending on the amount of prolactin hormone in your blood so that the incidence of unfavorable side effects can be eliminated. Treatment with Generic Cabergoline tablets should be carried on for a course of six months after the normal blood prolactin level has been attained. Your doctor may closely observe your blood prolactin levels through regular blood tests to verify the effectiveness of Caberdost tablets.
Cabergoline Tablets Dose For Lactation Suppression:

The suggested daily dosage of Generic Cabergoline tablets in women who wish to stop lactation immediately after childbirth is 1 mg of Caberdost tablets on the first day after delivery. The optimum dosage in women who wish to discontinue breastfeeding after they have started lactation is 0.25 mg Caberdost tablets every 12 hours for 2 days.
Treatment of hyperprolactinaemic disorders:
The dose of Caberdost initially recommended is of 0.5 mg/week administered in one or two intakes (half a tablet of 0.5 mg/week, for example on Monday and Thursday). The weekly dose should be gradually increased, preferably by adding 0.5 mg/week at monthly intervals until the optimal therapeutic response is achieved. The therapeutic dose is generally 1 mg/week, but it could vary from 0.25 mg to 2 mg/week.
Cabergoline Dosage for Bodybuilding:

The recommended dosage of Caberdost tablets (Generic Cabergoline tablets) for bodybuilders is generally 0.25 mg, administered twice a week. The maximum allowable dosage is 1 mg, administered twice a week. A dosage higher than 1 mg of Cabergoline tablets may result in the incidence of undesirable side effects.

Caberdost Mechanism of Action – How Does Cabergoline Work?

Caberdost tablets (Generic Cabergoline tablets) which are artificial versions of the dopamine neurotransmitter, behaves like a dopamine receptor agonist. Cabergoline impersonates the characteristics of the dopamine neurotransmitter which successfully impedes the pituitary gland from secreting prolactin hormone into the blood. It works by stopping the brain from making and releasing the prolactin hormone from the pituitary gland. Cabergoline use is usually stopped when prolactin levels are normal for 6 months. It may be given again if symptoms of too much prolactin occur again.

Caberdost Tablets - Missed Dose

If you miss your regular dose of Caberdost tablets (Generic Cabergoline tablets), take it as soon as you remember. You can continue your regular schedule the next day. If you remember the missed Caberdost tablets the next day, take your regular dose and skip the missed dose. Do not take a double dose to compensate the missed dose of Caberdost tablets.

Storage Instructions for Caberdost Tablets

Store the pack of Caberdost tablets (Generic Cabergoline) at room temperature (20 – 25°C), protected from heat, moisture, and sunlight. Retain the original packing of the medication and do not consume Cabergoline tablets (Caberdost) beyond its expiration date printed on the blister pack.
Keep the pack of Generic Cabergoline tablets away from the reach of children and pets. Do not discard Caberdost tablets along with domestic waste or sewage. Consult your doctor or pharmacist about the correct method of disposal.

Warnings and Precautions to be taken when using Caberdost Tablets

Medical History

Before beginning the treatment with Caberdost tablets (Generic Cabergoline tablets), discuss your personal and family medical history with your doctor. Inform your doctor if you have liver disease, high blood pressure (hypertension), heart valve disease, abnormal scarring/thickening of the lining in the lungs/heart/behind the abdomen(pulmonary/pericardial/retroperitoneal fibrosis), pregnant or breast-feeding, stomach ulcer, liver problems, circulation problem called Raynaud's syndrome, psychotic disorder, rare inherited blood disorder called porphyria. Pregnancy:
Dopamine agonists in general should not be used in patients with pregnancy-induced hypertension, for example, preeclampsia, eclampsia, and postpartum hypertension, unless the potential benefit is judged to outweigh the possible risk.
Cardiovascular
Cabergoline should be given with caution to subjects with cardiovascular disease and Raynaud's syndrome. Symptomatic hypotension can occur with cabergoline administration. Care should be exercised when administering cabergoline concomitantly with other drugs known to lower blood pressure.
Cardiac Valvulopathy
All patients should undergo a cardiovascular evaluation, including echocardiogram to assess the potential presence of valvular disease. If valvular disease is detected, the patient should not be treated with cabergoline
Gastrointestinal
Cabergoline should be given with caution to subjects with peptic ulcer and gastrointestinal bleeding.
Hepatic
Since cabergoline is extensively metabolised by the liver, caution should be used, and careful monitoring exercised, when administering cabergoline to patients with hepatic impairmen
Extracardiac Fibrotic Reactions
Postmarketing cases of pleural, pericardial, and retroperitoneal fibrosis have been reported following administration of cabergoline. Some reports were in patients previously treated with other ergotinic dopamine agonists. Cabergoline should not be used in patients with a history of cardiac or extracardiac fibrotic disorders.
Neurologic
Cabergoline has been associated with somnolence. Sudden sleep onset episodes that can be associated with dopamine agonists usually occur in patients with Parkinson's disease. A reduction of dosage or termination of therapy may be considered.
Psychiatric
Cabergoline should be given with caution to subjects with a history of mental disease.
Renal
Cabergoline should be given with caution to subjects with renal insufficiency
Cabergoline Tablets – Alcohol
Avoid or restrict alcohol consumption during the course of Cabergoline tablets.
Cabergoline Tablets – Driving and Other Activities
Caberdost tablets may make you light-headed or impair your vision. Avoid activities such as driving, using machinery, or performing any activity that requires complete vigilance or perfect vision until you are sure about your safety.
Surgery and Regular Medical Tests
If you plan to have surgery or any dental procedure, inform your doctor, anesthetist, or dentist about your course of Caberdost tablets (Generic Cabergoline tablets). In case of an emergency medical treatment, please inform the practitioner about your course of Caberdost tablets and the details of your last dose
Allergy
Please inform your doctor if you have an allergy or have had an allergic reaction in the past to Cabergoline or any inactive ingredient in Caberdost tablets (Generic Cabergoline tablets). Consult your doctor if you have developed any allergies to any other ergot medication in the past.

Cabergoline Interactions

Before beginning the oral therapy of Caberdost tablets, please inform your doctor of all your current medications including prescription drugs, over the counter medications, mineral supplements, herbal products, and vitamins. Cabergoline is known to interact with dopamine antagonists (phenothiazines, butyrophenones, thioxanthenes, and metoclopramide).
Other medications are known to hinder the working and effectiveness of Caberdost Tablets. Refer to your doctor if you are using azole antifungals (such as itraconazole, ketoconazole, posaconazole), cobicistat, macrolide antibiotics (such as clarithromycin, erythromycin), HIV protease inhibitors (such as ritonavir, saquinavir)

Caberdost Tablets Contraindications

The treatment with Caberdost tablets is contraindicated in patients who are allergic to Cabergoline or any inactive ingredients present in Caberdost tablets. Caberdost tablets are also contraindicated in patients with:

• Uncontrolled hypertension or known hypersensitivity to ergot derivatives.
• History of cardiac valvular disorders, as suggested by anatomical evidence of valvulopathy of any valve, determined by pre-treatment evaluation including echocardiographic demonstration of valve leaflet thickening, valve restriction, or mixed valve restriction-stenosis
• History of pulmonary, pericardial, or retroperitoneal fibrotic disorders
• Although there is no conclusive evidence of an interaction between Cabergoline and other ergot alkaloids (which are generally used for the treatment of migraine and headaches), the concomitant use of these medications during long-term therapy with Dostinex is not recommended.

Side Effects of Caberdost Tablets

The following side effects have been reported during the course of treatment with Caberdost tablets (Generic Cabergoline tablets):

• Cardiovascular System- low blood pressure, abnormal heart rhythm changes, chest pain.
• Central Nervous System- nausea, headache, dizziness, vertigo, mental/mood changes, insomnia, hallucinations, behavioral changes, depression, fainting, abnormal or unusual thoughts.
• Eye and ENT- nosebleeds, persistent cough, vision changes.
• Gastrointestinal System- constipation, stomach pain, indigestion.
• Genitourinary System- breast pain, painful menses, changes in the amount of urine.
• Musculoskeletal System- swelling in ankles/feet/hands, lower back/flank pain, uncontrollable muscle movements.
• Hypersensitivity-rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
• General- weakness, unusual tiredness, loss of appetite, hot flashes, hair loss.

Inform your doctor immediately if you experience any of these side effects. This is not a comprehensive list of all the possible side effects of Caberdost tablets. If you develop any other medical conditions during the course of treatment with Cabergoline tablets, please consult your doctor immediately.

Cabergoline (Caberdost Tablets) During Pregnancy and Breastfeeding

Cabergoline has been classified by the US FDA as Pregnancy Category B.
Reproduction studies have been performed with cabergoline in mice, rats, and rabbits administered by gavage. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this medication should be used during pregnancy only if clearly needed.
Do not use this medicine without your doctor's consent in case you are pregnant. Stop using this medication and inform your doctor immediately if you become pregnant during treatment.
Based on information from animal studies, excretion in human milk is very likely. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Cabergoline, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Buy Cabergoline 0.5 mg (Caberdost) Pills Online From Only $2.35 per Pill

You can buy Generic Cabergoline 0.5 mg tablets online from Everest Online Pharmacy at a cheap price. Caberdost 0.5 mg pills, manufactured by HAB Pharmaceuticals & Research Limited (Signature), India, are supplied in a box of 4 tablets. The 0.5 mg tablets cost only $2.35 per unit when you place an order for 200 tablets.

Disclaimer

The above information is provided to the best of our knowledge and in good faith. It is without a warrant of any kind, expressed or implied.

Shipping Restriction